{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "TTRAP",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "TTRAP M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PD-associated missense mutations specifically trigger a combined JNK-and p38-mediated apoptotic pathway in a TTRAP-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, indicating that TTRAP-associated mutations trigger apoptosis through specific signaling pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability was measured by MTT assay. Data are expressed as the percentage of untreated cells. Experiments have been repeated on three independent TTRAP and three control clones. *P<0.05.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (MTT assay for cell viability and immunoblot for PARP fragment detection) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "All experiments were repeated in duplicate or more. For stably transfected cells, at least two independent clones were used for each cell line in all experiments. Data represent the mean ± S.D.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that experiments were performed in duplicate or more, with at least two independent clones used for each cell line, indicating sufficient controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "TTRAP-dependent M26I and L166P pro-apoptotic activities were completely abolished after SP600125 and SB203580 co-administration proving that PD-associated missense mutations specifically trigger a combined JNK-and p38-mediated apoptotic pathway in a TTRAP-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The functional data for this variant shows a clear pathogenic effect, with pro-apoptotic activities being abolished by specific inhibitors, indicating a strong association with the disease mechanism."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The M26I variant in TTRAP shows strong functional evidence of pathogenicity, as its pro-apoptotic activity is abolished by specific JNK and p38 inhibitors, indicating a clear role in the disease mechanism. However, the evidence strength is classified as 'supporting' due to the lack of explicit OddsPath calculation or variant controls."
    },
    {
      "variant_id": {
        "Gene": "TTRAP",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "TTRAP L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PD-associated missense mutations specifically trigger a combined JNK-and p38-mediated apoptotic pathway in a TTRAP-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, indicating that TTRAP-associated mutations trigger apoptosis through specific signaling pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability was measured by MTT assay. Data are expressed as the percentage of untreated cells. Experiments have been repeated on three independent TTRAP and three control clones. *P<0.05.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (MTT assay for cell viability and immunoblot for PARP fragment detection) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "All experiments were repeated in duplicate or more. For stably transfected cells, at least two independent clones were used for each cell line in all experiments. Data represent the mean ± S.D.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that experiments were performed in duplicate or more, with at least two independent clones used for each cell line, indicating sufficient controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "TTRAP-dependent M26I and L166P pro-apoptotic activities were completely abolished after SP600125 and SB203580 co-administration proving that PD-associated missense mutations specifically trigger a combined JNK-and p38-mediated apoptotic pathway in a TTRAP-dependent manner.",
          "judgment": "Yes",
          "reasoning": "The functional data for this variant shows a clear pathogenic effect, with pro-apoptotic activities being abolished by specific inhibitors, indicating a strong association with the disease mechanism."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L166P variant in TTRAP shows strong functional evidence of pathogenicity, as its pro-apoptotic activity is abolished by specific JNK and p38 inhibitors, indicating a clear role in the disease mechanism. However, the evidence strength is classified as 'supporting' due to the lack of explicit OddsPath calculation or variant controls."
    }
  ]
}